HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie von Ziegenweidt Selected Research

Therapeutics

9/2015Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
6/2015Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
1/2015Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide.
10/2014Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.
1/2014Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
7/2013Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
6/2013Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study.
7/2012Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care.
10/2011Device type and real-world effectiveness of asthma combination therapy: an observational study.
9/2010Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie von Ziegenweidt Research Topics

Disease

17Asthma (Bronchial Asthma)
09/2015 - 01/2009
8Respiratory Tract Infections (Respiratory Tract Infection)
09/2015 - 09/2010
4Infections
10/2014 - 01/2010
2Chronic Obstructive Pulmonary Disease (COPD)
01/2014 - 06/2013
2Rhinitis
09/2010 - 01/2009
1Airway Obstruction (Choking)
01/2014
1Obstructive Lung Diseases (Obstructive Lung Disease)
01/2014
1Heart Diseases (Heart Disease)
01/2009

Drug/Important Bio-Agent (IBA)

17Adrenal Cortex Hormones (Corticosteroids)IBA
09/2015 - 01/2009
10Anti-Bacterial Agents (Antibiotics)IBA
09/2015 - 01/2010
5Beclomethasone (Beclometasone)FDA Link
10/2014 - 09/2010
4Fluticasone (Cutivate)FDA LinkGeneric
10/2014 - 09/2010
2SteroidsIBA
10/2014 - 01/2014
23- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
01/2014 - 01/2009
2apaflurane (hydrofluoroalkane)IBA
07/2013 - 09/2010
1Muscarinic AntagonistsIBA
01/2015
1Tiotropium Bromide (Spiriva)FDA Link
01/2015
1GoldIBA
01/2014
1Albuterol (Salbutamol)FDA LinkGeneric
01/2014
1Bronchodilator Agents (Bronchodilators)IBA
01/2014
1hydroxide ionIBA
01/2014
1Fluticasone-Salmeterol Drug Combination (Advair)FDA Link
10/2011
1Histamine Antagonists (Antihistamines)IBA
09/2010
1Mometasone Furoate (Nasonex)FDA LinkGeneric
09/2010

Therapy/Procedure

12Therapeutics
09/2015 - 01/2009
7Nebulizers and Vaporizers (Inhaler)
01/2014 - 01/2009
5Metered Dose Inhalers (Metered Dose Inhaler)
07/2013 - 01/2010
3Dry Powder Inhalers
10/2011 - 01/2010